Naughty Flicks

Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPROLivestreamMenuHere are the biggest calls on Wall Street on Wednesday: TD Cowen initiates Faeth Therapeutics as buy TD Cowen says the biotech company is firing on all cylinders. ” Faeth Therapeutics is a clinical-stage oncology company developing PIKTOR, an oral multi- node inhibitor of the PI3K/AKT/mTOR (PAM) pathway for solid tumors.” Barclays upgrades Sagimet Biosciences to overweight from equal weight Barclays says the dermatological biotech company has plenty of upside. “We recently caught up with SGMT. We increase our price target to $18 from $8 and upgrade to an Overweight rating from Equal Weight as we increase credit to acne and update our estimates after model review.” JPMorgan upgrades Lithium Americas to overweight from neutral JPMorgan sees an improving lithium outlook. “We therefore upgrade LAC to Overweight (from Neutral) and establish a Dec-27 $6 PT (no prior PT), implying 100% upside.” Bank of America upgrades Sasol to buy from neutral Bank of America says the South African oil company offers a compelling valuation. “We upgrade Sasol to Buy as we believe solid oil and refining macro along with a y/y increase in volumes…” Needham initiates Kodiak AI at buy Needham says the company is best positioned for autonomous trucking. “We initiate KDK with a Buy rating and an $8 target. KDK is well positioned to grow their presence in autonomous long haul trucking, messaging a removal of the safety observer from the vehicle by year-end, a visible proof point shifting the story from ‘does the technology work’ to ‘can the business scale.’” Roth initiates Pasqal at buy Roth says the quantum processing company has more room to run. “We are initiating coverage on Pasqal (PSQL) with a Buy rating and a $30 price target. Loop initiates Affirm at buy Loop says the buy now pay later platform is a “high quality growth story.” “We are initiating coverage of Affirm (AFRM) with a Buy rating and $105 12-month price target, viewing the company as one of the highest-quality growth stories in consumer fintech.” Read more. StoneX initiates Robinhood at buy The firm says operating metrics are “accelerating.” “We are initiating coverage of Robinhood Markets (HOOD) with a Buy rating and a $170 price target.” Loop initiates Chime at buy Loop says the fintech banking company is undervalued. “We are initiating coverage of Chime Financial, Inc. (CHYM) with a Buy rating and $45 12-month price target.” Loop initiates Dave at buy Loop says the company is one of the “most compelling monetization opportunities in fintech.” “We are initiating coverage on Dave Inc., (DAVE) with a Buy rating and $500 12-month price target.” Piper Sandler initiates Quanta Services at overweight The firm says that “Quanta is structurally positioned to outgrow a capex cycle the market still underestimates.” “We initiate coverage of Quanta Services (PWR ) with an OW rating and PT of $731, implying ~17% upside. Our FY28 revenue sits 5% above consensus and our 2030 revenue and EBITDA run ahead of the company’s own framework, reflecting our conviction that Quanta is structurally positioned to outgrow a capex cycle the market still underestimates.” UBS upgrades Thermo Fisher to buy from neutral UBS sees double digit growth. “We expect that TMO will durably return to at least 5-6% organic revenue growth in 2027, expand operating margin by at least 50-70bp and generate DD EPS growth.” Morgan Stanley upgrades Lineage to overweight from equal weight Morgan Stanley says the cold storage company is a “share gainer.” “In a slowing demand environment, tenants are likely to favor the highest-quality portfolio and best operators that are positioned to help with supply chain logistics and minimize transportation costs . LINE is likely to be a share gainer.” Piper Sandler initiates First Solar at overweight Piper says the solar company has robust margins. “We initiate coverage o f First Solar (FSLR) with an OW rating and PT of $260.” Jefferies initiates Liberty Formula One at buy Jefferies calls the company a “high-quality media & consumer experiences business.” “We initiate on FWONK at Buy with a $115 price target.” Read more. StoneX initiates Aptiv at buy StoneX says Aptiv has a differentiated offering. ‘We initiate coverage of Aptiv PLC with a Buy rating and a $75 price target, representing approximately 64% upside from current levels. We view ‘New Aptiv’ as a differentiated way to participate in the rising electronic and software content of vehicles, with exposure to ADAS, centralized compute, sensing, high-speed connectivity, and embedded software.” BMO initiates Abercrombie & Fitch at outperform BMO says the retailer has pulled off one of the “best turnarounds.” “We initiate at Outperform with a $170 target price . ANF has pulled off one of the best softlines turnarounds in history.” Jefferies initiates Pursuit Attractions & Hospitality at buy Jefferies says Pursuit is a “is a pure-play attractions/lodging business with strong organic & inorganic growth.” “We initiate on PRSU at Buy with a $61 price target. Oppenheimer initiates Atkis Oncology at outperform Oppenheimer says the radiopharma biotech company has a unique offering. “We are initiating coverage o f AKTS, a leader in the targeted radiopharmaceutical space, with an Outperform rating and $40 PT. RBC initiates AstraZeneca at outperform RBC says AstraZeneca shares have been “unfairly punished.” “Recent concerns and uncertain H2 catalysts create an attractive entry point. Short-term overhangs have overly punished AZN shares.” Evercore ISI reiterates Dell as outperform The investment bank raised its price target on Dell to $650 per share from $575. “Despite the move up in DELL shares, we see room for further appreciation, with the next phase driven by enterprise AI adoption, higher margin attach and continued OPEX leverage. Maintaining our OP and raising our target to $650, with upside at $1,000.” Leerink initiates Teva Pharmaceuticals at buy Leerink says Teva is a “growth story.” “We are initiating coverage of Teva Pharmaceuticals with an Outperform rating and a $45 Price Target.” Bank of America upgrades Figure to neutral from underperform Bank of America says fundamentals are getting better. “We are upgrading Figure Technology Solutions (FIGR) to Neutral from Underperform and raising our PO to $49 from $31.” Wells Fargo reiterates Tesla as underweight The bank says its Tesla survey checks show deliveries trending up month over month. “Of the 5 mkts we track, Aug TSLA deliveries are trending -4% y/y, though +45% m/m.” Bank of America reiterates Nvidia as buy Bank of America says its checks show Nvidia is one of the most owned stocks in its semis coverage. “In SPX, NVDA r emains most-owned semi, ahead of AVGO, then AMD.” Wells Fargo upgrades Martin Marietta to overweight from equal weight The firm says the building products company has plenty of upside ahead. “We upgrade MLM to Overweight from Equal Weight and make it our top pick…” Leerink initiates Bausch + Lomb at outperform Leerink says the eye care company has “multiple shots on goal.” “We are initiating coverage on Bausch + Lomb with an Outperform rating and $24 price target based on ~10.5x our CY27 EBITDA estimate of $1.2Bn.”Read More